TS

Trupti Sagar Shinde

Active Director Director DIN 08519171
DIN 08519171 First appointment Jul 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value •••• Premium profile

About Trupti Sagar Shinde

Data last updated:

Trupti Sagar Shinde is a Director at Vesuvius Pharma Private Limited (since 2019). The company operates in Healthcare. Vesuvius Pharma Private Limited reported revenue of ₹35.7 Lakh (FY 2025).

DIN 08519171
Primary Designation Director
Industry Healthcare
First Appointment 24 Jul 2019
Oldest Company Age 7 yrs
Largest company Vesuvius Pharma Private Limited · ₹35.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vesuvius Pharma Private Limited U33119PN2019PTC183766
Director24 Jul 20192019₹35.7 Lakh (FY 2025)Active

Board colleagues of Trupti Sagar Shinde

NameDINCompanyDesignation
Sagar Dilip Shinde08435471Vesuvius Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Vesuvius Pharma Private Limited
Premium access

Shareholding and investment profile for Trupti Sagar Shinde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Trupti Sagar Shinde

Trupti Sagar Shinde currently holds 1 directorship: Vesuvius Pharma Private Limited (Director, since 24 Jul 2019, revenue ₹35.7 Lakh (FY 2025)).

Trupti Sagar Shinde was first appointed on 24 Jul 2019 as Director at Vesuvius Pharma Private Limited.

The current boards of Trupti Sagar Shinde's companies include Sagar Dilip Shinde (Vesuvius Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available